254. Porphyria Clinical trials / Disease details


Clinical trials : 70 Drugs : 54 - (DrugBank : 19) / Drug target genes : 19 - Drug target pathways : 35

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02180412
(ClinicalTrials.gov)
April 28, 201425/6/2014Controlled Trial of Panhematin in Treatment of Acute Attacks of PorphyriaA Double-blind, Randomized, Placebo-controlled, Parallel Group Trial on the Efficacy and Safety of PanhematinTM in the Treatment of Acute Attacks of PorphyriaAcute PorphyriasBiological: Panhematin;Other: GlucoseThe University of Texas Medical Branch, GalvestonNULLActive, not recruiting18 Years100 YearsAll40Phase 2United States